Literature DB >> 31980958

Tumor budding is an adverse prognostic marker in intestinal-type sinonasal adenocarcinoma and seems to be unrelated to epithelial-mesenchymal transition.

Valeria Maffeis1, Rocco Cappellesso2, Francesca Galuppini2, Vincenza Guzzardo2, Alessia Zanon3, Diego Cazzador3,4, Enzo Emanuelli3, Laura Ventura5, Alessandro Martini3, Ambrogio Fassina2.   

Abstract

Intestinal-type adenocarcinoma (ITAC) of sinonasal tract is a rare malignant tumor with strong morphological, immunophenotypical, and molecular similarities to colorectal adenocarcinoma (CRC). Tumor budding (TB) is a well-established adverse prognostic marker in CRC and some head and neck tumors, with features of epithelial-mesenchymal transition (EMT). The aim of this study was to assess TB in ITAC and to evaluate its possible association with EMT markers in this setting. We selected 32 surgically resected specimens of non-mucinous/non-signet ring ITAC and evaluated them for TB according to the international recommendations developed for CRC. The expression of the EMT markers E-cadherin, ZEB1, ZEB2, SLUG, and SNAIL was evaluated by immunohistochemistry (IHC). Results were stratified using clinical and follow-up data (2/32 patients had metastatic disease and 4/32 died of disease). We observed TB in 13/32 (40.6%) ITAC cases including the 7 patients with relapse (p = 0.0005) and the 4 patients dead of disease (p = 0.02). Lymphovascular invasion was associated with TB (p = 0.008). Absence of TB was associated with low ZEB2 expression (p = 0.003). No other association with EMT markers emerged. Occupational exposure to wood and leather dust was not related to the presence of TB. TB interobserver concordance was substantial (proportion of agreement = 87%; Cohen's kappa = 0.73). This work suggests that TB is associated with a worse prognosis in ITAC, but our findings do not seem to support the involvement of EMT in this specific setting. Further larger studies are needed to address this point.

Entities:  

Keywords:  Epithelial-mesenchymal transition (EMT); Intestinal-type adenocarcinoma; Sinonasal cavities; Tumor budding

Mesh:

Substances:

Year:  2020        PMID: 31980958     DOI: 10.1007/s00428-020-02748-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  40 in total

Review 1.  Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.

Authors:  F Petrelli; E Pezzica; M Cabiddu; A Coinu; K Borgonovo; M Ghilardi; V Lonati; D Corti; S Barni
Journal:  J Gastrointest Cancer       Date:  2015-09

2.  Incidence and survival of sinonasal adenocarcinoma by site and histologic subtype.

Authors:  Suat Kılıç; Ruwaa Samarrai; Sarah S Kılıç; Mina Mikhael; Soly Baredes; Jean Anderson Eloy
Journal:  Acta Otolaryngol       Date:  2017-12-05       Impact factor: 1.494

3.  Low prevalence of K-RAS, EGF-R and BRAF mutations in sinonasal adenocarcinomas. Implications for anti-EGFR treatments.

Authors:  Alessandro Franchi; Duccio Rossi Degli Innocenti; Annarita Palomba; Lucia Miligi; Fabiola Paiar; Ciro Franzese; Marco Santucci
Journal:  Pathol Oncol Res       Date:  2013-12-15       Impact factor: 3.201

Review 4.  Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.

Authors:  Antti A Mäkitie; Alhadi Almangush; Juan P Rodrigo; Alfio Ferlito; Ilmo Leivo
Journal:  Head Neck       Date:  2019-07-22       Impact factor: 3.147

Review 5.  Tumor budding as a risk factor for nodal metastasis in pT1 colorectal cancers: a meta-analysis.

Authors:  Rocco Cappellesso; Claudio Luchini; Nicola Veronese; Marcello Lo Mele; Erik Rosa-Rizzotto; Ennio Guido; Franca De Lazzari; Pierluigi Pilati; Fabio Farinati; Stefano Realdon; Marco Solmi; Matteo Fassan; Massimo Rugge
Journal:  Hum Pathol       Date:  2017-04-22       Impact factor: 3.466

6.  Sinonasal cancer in the Italian national surveillance system: Epidemiology, occupation, and public health implications.

Authors:  Alessandra Binazzi; Marisa Corfiati; Davide Di Marzio; Anna M Cacciatore; Jana Zajacovà; Carolina Mensi; Paolo Galli; Lucia Miligi; Roberto Calisti; Elisa Romeo; Alessandro Franchi; Alessandro Marinaccio
Journal:  Am J Ind Med       Date:  2017-11-07       Impact factor: 2.214

7.  CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.

Authors:  A Franchi; D Massi; A Palomba; M Biancalani; M Santucci
Journal:  Virchows Arch       Date:  2004-06-03       Impact factor: 4.064

8.  Tumour budding is a strong and independent prognostic factor in pancreatic cancer.

Authors:  E Karamitopoulou; I Zlobec; D Born; A Kondi-Pafiti; P Lykoudis; A Mellou; K Gennatas; B Gloor; A Lugli
Journal:  Eur J Cancer       Date:  2012-11-21       Impact factor: 9.162

Review 9.  RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer.

Authors:  Valeria Maffeis; Lorenzo Nicolè; Rocco Cappellesso
Journal:  Front Oncol       Date:  2019-11-19       Impact factor: 6.244

10.  Tumour budding in oral squamous cell carcinoma: a meta-analysis.

Authors:  Alhadi Almangush; Matti Pirinen; Ilkka Heikkinen; Antti A Mäkitie; Tuula Salo; Ilmo Leivo
Journal:  Br J Cancer       Date:  2017-11-30       Impact factor: 7.640

View more
  2 in total

Review 1.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

2.  Reappraisal of Grading in Intestinal-Type Sinonasal Adenocarcinoma: Tumor Budding as an Independent Prognostic Parameter.

Authors:  Christian M Meerwein; Muriel D Brada; Michael B Soyka; David Holzmann; Niels J Rupp
Journal:  Head Neck Pathol       Date:  2022-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.